Abbott’s Libre 3 gets FDA clearance
Having already received a CE mark in September 2020 for FreeStyle Libre 3 (FSL3), the latest version of its continuous glucose monitor, Abbott has now
Having already received a CE mark in September 2020 for FreeStyle Libre 3 (FSL3), the latest version of its continuous glucose monitor, Abbott has now
Abbott, the global healthcare company, today announced that its FreeStyle Libre 3 continuous glucose monitoring (CGM) system, the latest addition to the world-leading FreeStyle Libre
Dexcom’s G7 is the next-generation continuous glucose monitoring (CGM) system building on the best-selling real-time CGM in the world. It is now more powerful and
A raft of new products to reduce the chore of living with diabetes, are in the pipeline from Dexcom. The innovations called G7, a new
Ascensia Diabetes Care has launched a patient assistance programme in the US to provide broader access to its Eversense CGM system. Under the programme eligible
By Ricky Zipp writing for MedTechDive July 2021, “Dexcom wins FDA nod for real-time artificial pancreas systems (APIs), allowing third-party developers access to CGM data
Dexcom has presented promising results from two studies of continuous glucose monitors, including its next-generation G7 CGM, reports Drug Delivery Business. The first study –
A food intelligence company has raised $4m in funding to start shipping its app which scans Abbott’s Freestyle Libre to help people monitor their blood
Dexcom revealed Nick Jonas as their newest Global Warrior during America’s recent Super Bowl event. A multi-platinum recording artist, actor and philanthropist, Jonas was diagnosed
A violinist by trade, Olivia Holland was diagnosed with Type 1 diabetes at the age of 17, ten years ago. At the time, she was